Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Artemis Global Life Sciences

Sector: Healthcare | Industry: Drugs & Pharma
R 48.10 -1.00  | -2.04% -35.87% 17.17 362.38
NSE Price: Oct 14, 15:32 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Oct 14, 15:32 48.10 -1.00 -2.04% 49.00 49.10 5,797 48.05 - 49.50
BSE Oct 14, 15:41 49.00 0.00 0.00% 54.75 49.00 2 49.00 - 54.75
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE FREE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 4,691 P/B: 1.56 NSE Code: AGLSL
52-Week Range: R 43.00 - 81.50 Dividend Yield: 0.00% BSE Code: 540616
TTM EPS: R 3.19 Book Value: R 35.06 Face Value: R 2
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Are you missing an opportunity to invest in great stocks at low valuations?
There are thousands of listed companies in India and yet only a handful that are worth investing at a particular time and at a particular price.

Our equity team has sifted through hundreds of companies and selected stocks that you should invest in. This list now has 38 stocks on it, and new ones are being added every month. Thousands of our members are using stagnant equity markets to buy great stocks at low prices. Membership of Value Research Stock Advisor is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Artemis Global Life Sciences -23.46 -7.10 -2.19 -29.76 - - -
S&P BSE Small Cap -13.15 -0.93 -7.15 -7.45 -1.23 3.77 5.64
S&P BSE Healthcare -12.72 -6.94 -5.50 -15.31 -9.36 -2.37 10.68
Company's return has been calculated on basis of NSE's price.
As on Oct 11, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 0.00 - -
Net Profit 60.88 -217.10 -278.57
EPS 60.75 -122.99 14.52
Book Value -0.07 113.77 33.95
Average
Unable to fetch data.
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -3.17 7.34 -3.17
Operating Profit -19.96 19.36 -19.96
Net Profit -22.07 16.75 -22.07
EPS -23.46 16.85 -23.46
TTM
Revenue 1.70 8.95 1.70
Operating Profit 3.68 8.69 3.68
Net Profit 3.00 -21.20 3.00
EPS 3.00 -20.80 3.00
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Artemis Global Life Sciences 362.38 555.79 21.00 3.76 9.36 1.56 17.17
Astrazeneca Pharma India 5,470.13 771.42 69.56 8.84 20.03 17.08 78.64
Eris Lifesciences 5,935.35 1,005.70 303.64 29.29 28.96 4.81 19.55
Fund Houses invested in the stock
Fund Sep-17 Jun-17 Mar-17 Dec-16 Sep-16
Sundaram Mutual Fund 0.003 0.003 0.003 - -
Figures given above are % of equity capital
News & Announcements
Contact Information

Company: Artemis Global Life Sciences Ltd.

Address: 414/1, 4th Floor, Dda Commercial Complex, District Centre, Janakpuri, New Delhi, Delhi - 110058 | Phone: 0124-4262305/07 | Fax: 0124-4262306

Email: [email protected]

Website: www.aglsl.in

Registrar & Transfer Agent: Alankit Assignments Ltd

Address: 205-208 , Anarkali Complex,Jhandewala Extension,New Delhi, 205-208 , Anarkali Complex, Jhandewala Extension | Phone: 011-23610220-24 | Fax: 011-23552001

Essential checks
Altman Z-Score
2.61
Piotroski F-Score
5
Modified C-Score
3
1-Year Price to Earnings
15.37
1-Year Price to Book
1.40
Earnings Yield
EBIT / Enterprise value
11.66%
PEG
Price / Earnings to growth ratio
Not available
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,170.35 -1.31%
Caplin Point Laboratories R402.05 +0.59%
Eris Lifesciences R432.25 +1.02%
FDC R160.15 -1.84%
JB Chemicals & Pharma R359.50 -0.26%
Laurus Labs R319.90 -2.04%
Strides Pharma Science R338.50 +4.35%
Sun Pharma Adv. Research R118.85 +2.59%
Suven Life Sciences R258.20 +0.12%
Wockhardt R253.70 +1.20%
As on Oct 14, 15:32